Phase II/III study of relatlimab with nivolumab in melanoma meets PFS primary endpoint March 25, 2021
First patient dosed in phase I study of TH-1902 as treatment of sortilin-positive solid tumors March 25, 2021
Corectim Ointment 0.25% and 0.5% approved in Japan as treatment of pediatric atopic dermatitis March 25, 2021
Uplizna gains Japanese approval for the treatment of neuromyelitis optica spectrum disorder March 25, 2021
RSS